Bridgeway Capital Management’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $139K | Hold |
12,500
| – | – | ﹤0.01% | 1023 |
|
|
2025
Q1 | $175K | Hold |
12,500
| – | – | ﹤0.01% | 950 |
|
|
2024
Q4 | $208K | Hold |
12,500
| – | – | ﹤0.01% | 1002 |
|
|
2024
Q3 | $237K | Buy |
+12,500
| New | +$237K | 0.01% | 1025 |
|
|
2024
Q2 | – | Sell |
-7,500
| Closed | -$116K | – | 1316 |
|
|
2024
Q1 | $116K | Buy |
+7,500
| New | +$116K | ﹤0.01% | 1192 |
|
|
2020
Q2 | – | Sell |
-3,605
| Closed | -$257K | – | 1360 |
|
|
2020
Q1 | $257K | Buy |
+3,605
| New | +$257K | 0.01% | 981 |
|
|
2019
Q4 | – | Sell |
-7,630
| Closed | -$612K | – | 1362 |
|
|
2019
Q3 | $612K | Buy |
7,630
+355
| +5% | +$28.5K | 0.01% | 868 |
|
|
2019
Q2 | $469K | Hold |
7,275
| – | – | 0.01% | 993 |
|
|
2019
Q1 | $1M | Buy |
+7,275
| New | +$1M | 0.01% | 767 |
|